Mortality in Patients with Multiple Sclerosis

Sümeyra Şamlı, Murat Kürtüncü

DOI: 10.4274/tnd.15921

Issue: 2018, Volume 24 - Issue 1
0 418

Fampridine Therapy in Multiple Sclerosis: We Should Think Twice!

Mohamed S A Mohamed

DOI: 10.4274/tnd.65882

Issue: 2018, Volume 24 - Issue 1
0 295

Intravenous Thrombolytic Therapy in Acute Stroke: Problems and Solutions

Mehmet Akif Topçuoğlu, Ethem Murat Arsava, Atilla Özcan Özdemir, Erdem Gürkaş, Dilek Necioğlu Örken, Şerefnur Öztürk

DOI: 10.4274/tnd.71084

Issue: 2017, Volume 23 - Issue 4
0 490

Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis

Burcu Altunrende, Erkingül Birday, Mithat Kasap, Gülşen Akman Demir

DOI: 10.4274/tnd.62144

Issue: 2017, Volume 23 - Issue 4
0 486

Intravenous Thrombolytic Therapy in Acute Ischemic Stroke: The Experience of Kütahya

Mustafa Çetiner, Sibel Canbaz Kabay, Hasan Emre Aydın

DOI: 10.4274/tnd.35651

Issue: 2017, Volume 23 - Issue 4
0 385

Quality of Life, Coping, and Social Support in Patients with Multiple Sclerosis: A Pilot Study

Oğuzhan Zengin, Ercüment Erbay, Buğra Yıldırım, Özgür Altındağ

DOI: 10.4274/tnd.37074

Issue: 2017, Volume 23 - Issue 4
0 522

Flow Cytometry Analysis of Peripheral Blood B Cell Distribution of Patients with Multiple Sclerosis

Vuslat Yılmaz, Deniz Ak Tura, Canan Ulusoy, Duygu Özkan Yaşargün, Suzan Adın Çınar, Recai Türkoğlu

DOI: 10.4274/tnd.87523

Issue: 2017, Volume 23 - Issue 4
0 362

Acute Spinal Pseudoathetosis

Mehmet Fevzi Öztekin, Dilara Mermi Dibek

DOI: 10.4274/tnd.27167

Issue: 2017, Volume 23 - Issue 4
0 283

Weight Loss and Fingolimod

Nefati Kıylıoğlu

DOI: 10.4274/tnd.87528

Issue: 2017, Volume 23 - Issue 4
0 294

Balint Syndrome due to Bilateral Parieto-occipital Ischemic Stroke

Halil Önder

DOI: 10.4274/tnd.69862

Issue: 2017, Volume 23 - Issue 4
0 318

Ischemic Stroke Subtypes and Migraine with Visual Aura

Çağla Akı

DOI: 10.4274/tnd.98623

Issue: 2017, Volume 23 - Issue 4
0 358

Clinical Features of Cerebral Venous Sinus Thrombosis

Ezgi Sezer Eryıldız, Atilla Özcan Özdemir

DOI: 10.4274/tnd.43402

Issue: 2017, Volume 23 - Issue 3
0 368

One-year Risk of Stroke after Transient Ischemic Attack or Minor Stroke

Mustafa Karaoğlan

DOI: 10.4274/tnd.37097

Issue: 2017, Volume 23 - Issue 3
0 376

The Effect of Ocrelizumab in the Treatment of Multipl Sclerosis

Şenay Yıldız Çelik

DOI: 10.4274/tnd.71354

Issue: 2017, Volume 23 - Issue 3
0 313

Amiselimod: A New Oral Agent in the Treatment of Multiple Sclerosis

Ahmed Serkan Emekli

DOI: 10.4274/tnd.90018

Issue: 2017, Volume 23 - Issue 3
0 284

A Case of Ischemic Cerebellar Stroke with Alcoholic Cardiomyopathy

Yasemin Akıncı, Fatma Özer, Örsan Deniz Urgun, Derya Uludüz, Baki Göksan

DOI: 10.4274/tnd.45403

Issue: 2017, Volume 23 - Issue 3
0 280

Evaluation of the Effects of Adipocytokines on Prognosis in Ischemic Cerebrovascular Events

Muzaffer Şükriye Aliye Türkeş Demir, Özge Arıcı Düz, Nihal Işık

DOI: 10.4274/tnd.02170

Issue: 2017, Volume 23 - Issue 2
0 368

Amnesia due to Bilateral Fornix Infarction

Çetin Kürşad Akpınar, İdris Sayılır

DOI: 10.4274/tnd.98958

Issue: 2017, Volume 23 - Issue 2
0 379

A Case of Neuro-AIDS Presenting with Rapidly Progressive Dementia and Parkinsonism with Rapid Response to Treatment

Yasemin Akıncı, Melis Sohtaoğlu Sevindik, Bilgül Mete, Umran Şumeyse Ertürk, Mehmet Yürüyen, Bekir Sami Kocazeybek, Melda Bozluolcay

DOI: 10.4274/tnd.94758

Issue: 2017, Volume 23 - Issue 2
0 308

Relationship Between Ischemic Stroke Subtypes and Migraine with Visual Aura

İpek Güngör Doğan

DOI: 10.4274/tnd.67934

Issue: 2017, Volume 23 - Issue 2
0 303